Logo

Bruker's Q3 Revenues Rise 22 Percent as Profit Increases by a Third

Nov 02, 2006
NEW YORK (GenomeWeb News) — Bruker Biosciences’ third-quarter revenue increased 22 percent as income jumped by a third, the company said today.
 
Receipts for the three months ended Sept. 30 rose to $104.8 million from $85.9 million year over year. Product revenues were up 22 percent to $50.1 million and receipts from the company’s services business tallied $8 million, a third more than the same period last year.
 
The company attributed much of the revenue growth to its acquisition of Bruker Optics for $135 million in July.
 
Bruker said it will continue to look for ways to improve organic earnings in its core business.      
 
Spending on research and development remained flat at $12 million.
 
Bruker said profits in the period increased by a third to $3 million.
 
The company said it had around $44.1 million in cash and short term investments as of Sept. 30.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.